Literature DB >> 25708857

Mechanisms of mRNA frame maintenance and its subversion during translation of the genetic code.

Jack A Dunkle1, Christine M Dunham2.   

Abstract

Important viral and cellular gene products are regulated by stop codon readthrough and mRNA frameshifting, processes whereby the ribosome detours from the reading frame defined by three nucleotide codons after initiation of translation. In the last few years, rapid progress has been made in mechanistically characterizing both processes and also revealing that trans-acting factors play important regulatory roles in frameshifting. Here, we review recent biophysical studies that bring new molecular insights to stop codon readthrough and frameshifting. Lastly, we consider whether there may be common mechanistic themes in -1 and +1 frameshifting based on recent X-ray crystal structures of +1 frameshift-prone tRNAs bound to the ribosome.
Copyright © 2015 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Frameshifting; Protein synthesis; RNA structure; Ribosome; Translocation

Mesh:

Substances:

Year:  2015        PMID: 25708857      PMCID: PMC4458409          DOI: 10.1016/j.biochi.2015.02.007

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  64 in total

Review 1.  Recoding: translational bifurcations in gene expression.

Authors:  Pavel V Baranov; Raymond F Gesteland; John F Atkins
Journal:  Gene       Date:  2002-03-20       Impact factor: 3.688

Review 2.  The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting.

Authors:  Ewan P Plant; Kristi L Muldoon Jacobs; Jason W Harger; Arturas Meskauskas; Jonathan L Jacobs; Jennifer L Baxter; Alexey N Petrov; Jonathan D Dinman
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

3.  A new model for phenotypic suppression of frameshift mutations by mutant tRNAs.

Authors:  Q Qian; J N Li; H Zhao; T G Hagervall; P J Farabaugh; G R Björk
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

4.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Frameshift suppressors. II. Genetic mapping and dominance studies.

Authors:  D L Riddle; J R Roth
Journal:  J Mol Biol       Date:  1972-05-28       Impact factor: 5.469

6.  Reading two bases twice: mammalian antizyme frameshifting in yeast.

Authors:  S Matsufuji; T Matsufuji; N M Wills; R F Gesteland; J F Atkins
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

7.  Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway.

Authors:  Ashton Trey Belew; Arturas Meskauskas; Sharmishtha Musalgaonkar; Vivek M Advani; Sergey O Sulima; Wojciech K Kasprzak; Bruce A Shapiro; Jonathan D Dinman
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

8.  An extended signal involved in eukaryotic -1 frameshifting operates through modification of the E site tRNA.

Authors:  Michaël Bekaert; Jean-Pierre Rousset
Journal:  Mol Cell       Date:  2005-01-07       Impact factor: 17.970

9.  Expression of a coronavirus ribosomal frameshift signal in Escherichia coli: influence of tRNA anticodon modification on frameshifting.

Authors:  I Brierley; M R Meredith; A J Bloys; T G Hagervall
Journal:  J Mol Biol       Date:  1997-07-18       Impact factor: 5.469

10.  Structural probing and mutagenic analysis of the stem-loop required for Escherichia coli dnaX ribosomal frameshifting: programmed efficiency of 50%.

Authors:  B Larsen; R F Gesteland; J F Atkins
Journal:  J Mol Biol       Date:  1997-08-08       Impact factor: 5.469

View more
  9 in total

1.  Importance of a tRNA anticodon loop modification and a conserved, noncanonical anticodon stem pairing in tRNACGGProfor decoding

Authors:  Ha An Nguyen; Eric D Hoffer; Christine M Dunham
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

Review 2.  Viral Evasion and Manipulation of Host RNA Quality Control Pathways.

Authors:  J Robert Hogg
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

3.  Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Authors:  Joseph A Kendra; Cynthia de la Fuente; Ashwini Brahms; Caitlin Woodson; Todd M Bell; Bin Chen; Yousuf A Khan; Jonathan L Jacobs; Kylene Kehn-Hall; Jonathan D Dinman
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Investigating the consequences of mRNA modifications on protein synthesis using in vitro translation assays.

Authors:  Jeremy G Monroe; Tyler J Smith; Kristin S Koutmou
Journal:  Methods Enzymol       Date:  2021-07-29       Impact factor: 1.682

5.  Coupling of mRNA Structure Rearrangement to Ribosome Movement during Bypassing of Non-coding Regions.

Authors:  Jin Chen; Arthur Coakley; Michelle O'Connor; Alexey Petrov; Seán E O'Leary; John F Atkins; Joseph D Puglisi
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

6.  The ATPase Fap7 Tests the Ability to Carry Out Translocation-like Conformational Changes and Releases Dim1 during 40S Ribosome Maturation.

Authors:  Homa Ghalei; Juliette Trepreau; Jason C Collins; Hari Bhaskaran; Bethany S Strunk; Katrin Karbstein
Journal:  Mol Cell       Date:  2017-09-07       Impact factor: 17.970

7.  Model of the pathway of -1 frameshifting: Long pausing.

Authors:  Ping Xie
Journal:  Biochem Biophys Rep       Date:  2016-01-29

8.  Model of the pathway of -1 frameshifting: Kinetics.

Authors:  Ping Xie
Journal:  Biochem Biophys Rep       Date:  2016-02-10

9.  Structural insights into mRNA reading frame regulation by tRNA modification and slippery codon-anticodon pairing.

Authors:  Eric D Hoffer; Samuel Hong; S Sunita; Tatsuya Maehigashi; Ruben L Gonzalez; Paul C Whitford; Christine M Dunham
Journal:  Elife       Date:  2020-10-05       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.